• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症治疗中的补充方法——是福还是祸?

Complementary Methods in Cancer Treatment-Cure or Curse?

机构信息

Department of Gynecological Surgery and Oncology of Adults and Adolescents, Pomeranian Medical University, al. Powstańców Wielkopolskich 72, 70-111 Szczecin, Poland.

出版信息

Int J Environ Res Public Health. 2021 Jan 5;18(1):356. doi: 10.3390/ijerph18010356.

DOI:10.3390/ijerph18010356
PMID:33466517
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7796472/
Abstract

(1) Background: The prevalence of complementary and alternative methods (CAM) use among oncological patients has been rising constantly over the last few decades and a variety of both pharmacological and non-pharmacological methods have been developed. Many advertisements promise to relieve side effects of chemotherapy or even to cure the disease, thus encouraging patients to use CAM; (2) Methods: The objective of the study was to determine which patients' characteristics are associated with the use of complementary medicine during cancer treatment, their pattern of use, and if it has any association with its safety profile. This survey-based prospective multicenter study of 316 patients examined the use of complementary medicine among patients undergoing chemotherapy treatment in cancer centers in Poland between 2017 and 2019; (3) Results: The Chi2 analysis showed that patients' opinion regarding the safety of unconventional methods is related to the use of CAM ( = 0.00147). Moreover, patients' thinking that alternative medicine can replace traditional therapy was correlated with his/her education ( = 0.01198). Moreover, we performed univariate and multivariate analysis to determine factors associated with CAM use including sociodemographic and clinical characteristics. Finally, we conducted survival analysis of patients undergoing chemotherapy treatment with 42 months of follow-up time of our prospective study. Using Kaplan-Meier curves and log-rank analysis, we found no statistical difference in overall survival between the groups that used and did not use any form of CAM ( = 0.211); (4) Conclusions: CAM use is common among patients undergoing chemotherapy treatment and should be considered by medical teams as some agents may interact with chemotherapy drugs and affect their efficacy or cause adverse effects.

摘要

(1)背景:在过去几十年中,肿瘤患者对补充和替代方法(CAM)的使用不断增加,并且已经开发了各种药理学和非药理学方法。许多广告承诺可以缓解化疗的副作用,甚至可以治愈疾病,从而鼓励患者使用 CAM;(2)方法:本研究的目的是确定哪些患者特征与癌症治疗期间使用补充医学有关,他们的使用模式,以及它是否与安全性有关。这项基于调查的前瞻性多中心研究对 2017 年至 2019 年期间在波兰癌症中心接受化疗治疗的 316 名患者进行了检查,以研究补充医学的使用情况;(3)结果:卡方分析表明,患者对非常规方法安全性的看法与 CAM 的使用有关(= 0.00147)。此外,患者认为替代医学可以替代传统疗法与他/她的教育程度有关(= 0.01198)。此外,我们进行了单变量和多变量分析,以确定与 CAM 使用相关的因素,包括社会人口统计学和临床特征。最后,我们对接受化疗治疗的患者进行了生存分析,前瞻性研究的随访时间为 42 个月。使用 Kaplan-Meier 曲线和对数秩分析,我们发现使用和不使用任何形式的 CAM 的患者之间的总生存率没有统计学差异(= 0.211);(4)结论:CAM 的使用在接受化疗治疗的患者中很常见,医疗团队应予以考虑,因为某些药物可能会与化疗药物相互作用,影响其疗效或引起不良反应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/7a1a0a5d30b4/ijerph-18-00356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/40e5dc21b843/ijerph-18-00356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/f9978ee09e52/ijerph-18-00356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/7a1a0a5d30b4/ijerph-18-00356-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/40e5dc21b843/ijerph-18-00356-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/f9978ee09e52/ijerph-18-00356-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e5c9/7796472/7a1a0a5d30b4/ijerph-18-00356-g003.jpg

相似文献

1
Complementary Methods in Cancer Treatment-Cure or Curse?癌症治疗中的补充方法——是福还是祸?
Int J Environ Res Public Health. 2021 Jan 5;18(1):356. doi: 10.3390/ijerph18010356.
2
Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.加纳癌症放疗和化疗患者中补充和替代医学使用者的特征及其应用意义:一项横断面研究。
BMC Complement Altern Med. 2013 Jan 19;13:16. doi: 10.1186/1472-6882-13-16.
3
Complementary and alternative medicine in multiple sclerosis: a questionnaire-based study.多发性硬化症中的补充和替代医学:基于问卷的研究。
Neurol Neurochir Pol. 2022;56(5):428-434. doi: 10.5603/PJNNS.a2022.0059. Epub 2022 Sep 7.
4
The use of complementary and alternative medicine (CAM) among cancer patients at a tertiary hospital in Malaysia.马来西亚一家三级医院癌症患者对补充和替代医学(CAM)的使用情况。
Complement Ther Med. 2020 May;50:102343. doi: 10.1016/j.ctim.2020.102343. Epub 2020 Mar 8.
5
Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.癌症患者中补充和替代医学的患病率、模式及感知价值:一项横断面描述性研究。
BMC Complement Altern Med. 2017 Jun 30;17(1):345. doi: 10.1186/s12906-017-1853-6.
6
[Physicians attitudes towards complementary and alternative medicine in patients with cancer: preliminary report from pediatric and oncology centers].[医生对癌症患者补充和替代医学的态度:儿科和肿瘤中心的初步报告]
Med Wieku Rozwoj. 2008 Oct-Dec;12(4 Pt 2):1148-54.
7
Complementary and alternative medicine practices among Asian radiotherapy patients.亚洲放疗患者的补充和替代医学实践
Asia Pac J Clin Oncol. 2010 Dec;6(4):357-63. doi: 10.1111/j.1743-7563.2010.01296.x.
8
Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany.使用补充和替代医学(CAM)作为肿瘤治疗的一部分:关于德国一家大学肿瘤中心患者对CAM态度的调查。
PLoS One. 2016 Nov 3;11(11):e0165801. doi: 10.1371/journal.pone.0165801. eCollection 2016.
9
Complementary and Alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland.住院癌症患者中补充和替代医学的使用-来自波兰西里西亚的研究。
Int J Environ Res Public Health. 2022 Jan 30;19(3):1600. doi: 10.3390/ijerph19031600.
10
Integrating complementary medicine and supportive care: patients' perspectives toward complementary medicine and spirituality.整合补充医学和支持性护理:患者对补充医学和灵性的看法。
J Altern Complement Med. 2012 Sep;18(9):824-31. doi: 10.1089/acm.2011.0327.

引用本文的文献

1
Perforin 1 in Cancer: Mechanisms, Therapy, and Outlook.穿孔素 1 在癌症中的作用:机制、治疗和展望。
Biomolecules. 2024 Jul 26;14(8):910. doi: 10.3390/biom14080910.
2
Survey of Physicians and Healers Using Amygdalin to Treat Cancer Patients.医生和治疗师使用苦杏仁苷治疗癌症患者的调查。
Nutrients. 2024 Jun 28;16(13):2068. doi: 10.3390/nu16132068.
3
Self-Medication during and after Cancer: A French Nation-Wide Cross-Sectional Study.癌症期间及之后的自我药疗:一项法国全国性横断面研究。

本文引用的文献

1
Pharmacological ascorbate inhibits pancreatic cancer metastases via a peroxide-mediated mechanism.药物性抗坏血酸通过过氧化物介导的机制抑制胰腺癌转移。
Sci Rep. 2020 Oct 19;10(1):17649. doi: 10.1038/s41598-020-74806-2.
2
Herbal Interaction With Chemotherapeutic Drugs-A Focus on Clinically Significant Findings.草药与化疗药物的相互作用——聚焦于具有临床意义的发现
Front Oncol. 2019 Dec 3;9:1356. doi: 10.3389/fonc.2019.01356. eCollection 2019.
3
The Effect of Vitamin C (Ascorbic Acid) in the Treatment of Patients with Cancer: A Systematic Review.
Cancers (Basel). 2023 Jun 15;15(12):3190. doi: 10.3390/cancers15123190.
4
Online Medical Misinformation in Cancer: Distinguishing Fact From Fiction.网络癌症医疗谣言:辨别真假。
JCO Oncol Pract. 2022 Aug;18(8):584-589. doi: 10.1200/OP.21.00764. Epub 2022 Mar 31.
5
Complementary and Alternative Medicine Use in Hospitalized Cancer Patients-Study from Silesia, Poland.住院癌症患者中补充和替代医学的使用-来自波兰西里西亚的研究。
Int J Environ Res Public Health. 2022 Jan 30;19(3):1600. doi: 10.3390/ijerph19031600.
6
Growth, Proliferation and Metastasis of Prostate Cancer Cells Is Blocked by Low-Dose Curcumin in Combination with Light Irradiation.低剂量姜黄素联合光照可抑制前列腺癌细胞的生长、增殖和转移。
Int J Mol Sci. 2021 Sep 15;22(18):9966. doi: 10.3390/ijms22189966.
维生素 C(抗坏血酸)治疗癌症患者的效果:系统评价。
Nutrients. 2019 Apr 28;11(5):977. doi: 10.3390/nu11050977.
4
Complementary Medicine, Refusal of Conventional Cancer Therapy, and Survival Among Patients With Curable Cancers.补充医学、拒绝常规癌症治疗与可治愈癌症患者的生存。
JAMA Oncol. 2018 Oct 1;4(10):1375-1381. doi: 10.1001/jamaoncol.2018.2487.
5
Systematic Review of Intravenous Ascorbate in Cancer Clinical Trials.癌症临床试验中静脉注射维生素C的系统评价。
Antioxidants (Basel). 2018 Jul 12;7(7):89. doi: 10.3390/antiox7070089.
6
Use of Alternative Medicine for Cancer and Its Impact on Survival.癌症的替代医学治疗及其对生存的影响。
J Natl Cancer Inst. 2018 Jan 1;110(1). doi: 10.1093/jnci/djx145.
7
Trends in the use of complementary health approaches among adults: United States, 2002-2012.2002 - 2012年美国成年人使用补充健康方法的趋势
Natl Health Stat Report. 2015 Feb 10(79):1-16.
8
Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review.口服或静脉注射抗坏血酸(维生素C)在治疗癌症患者中是否起作用?一项系统评价。
Oncologist. 2015 Feb;20(2):210-23. doi: 10.1634/theoncologist.2014-0381. Epub 2015 Jan 19.
9
Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.综合癌症中心妇科癌症门诊患者中,补充和替代医学与癌症治疗的潜在相互作用。
J Cancer Res Clin Oncol. 2013 Mar;139(3):357-65. doi: 10.1007/s00432-012-1336-6. Epub 2012 Oct 26.
10
Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.圣约翰草(贯叶金丝桃)的草药-药物相互作用:临床观察的最新更新。
AAPS J. 2009 Dec;11(4):710-27. doi: 10.1208/s12248-009-9146-8. Epub 2009 Oct 27.